{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:10:36Z","timestamp":1790205036558,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG015379"],"award-info":[{"award-number":["P01AG015379"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Davis APP grant from the Shelby Collum Davis Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diffusible A\u03b2 oligomers (oA\u03b2) confer cytotoxicity in Alzheimer\u2019s disease. The dynamic complexity of this hydrophobic analyte means few immunoassays exist to quantify oA\u03b2 in CSF and plasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We characterized antibody 71A1 to a cyclized dimer of A\u03b29-18 for oA\u03b2 preference over monomers by surface plasmon resonance. We improved an earlier bead-based immunoassay by using 71A1 streptavidin plates for capture and N-terminal antibody 3D6 for detection. Numerous controls systematically validated accuracy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>71A1 showed highly selective binding kinetics to A\u03b2 oligomers over monomers. It enriched bioactive oligomers from AD brain that altered neuronal excitatory currents and calcium transients. 71A1\/3D6 immunoassay exhibited specificity and reproducibility in human biofluids. CSF oA\u03b2 levels correlated positively with CSF tau and phosphorylated-tau-181. APP and PS1 FAD mutations increased oA\u03b2 levels in human neuronal media.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CSF oA\u03b2 levels rise in concert with rising tau levels. A new plate-based ELISA offers improved consistency, less sample volume, and lower cost, thus better suited to quantify this challenging analyte.\n<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01802-x","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T02:33:47Z","timestamp":1752287627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An improved immunoassay detects A\u03b2 oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels"],"prefix":"10.1186","volume":"17","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendran","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Lish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Ostaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Young-Pearse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeer P.","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trebor L.","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"11","key":"1802_CR1","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11):6448\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6880","key":"1802_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535\u20139.","journal-title":"Nature"},{"issue":"4","key":"1802_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci. 2007;27(4):796\u2013807.","journal-title":"J Neurosci"},{"issue":"10","key":"1802_CR4","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009;106(10):4012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1802_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-6-1","volume":"6","author":"CM Sondag","year":"2009","unstructured":"Sondag CM, Dhawan G, Combs CK. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation. 2009;6: 1.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1802_CR6","doi-asserted-by":"publisher","first-page":"e8931","DOI":"10.15252\/emmm.201808931","volume":"10","author":"H Xu","year":"2018","unstructured":"Xu H, Rajsombath MM, Weikop P, Selkoe DJ. Enriched environment enhances beta-adrenergic signaling to prevent microglia inflammation by amyloid-beta. EMBO Mol Med. 2018;10(9):e8931.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"1802_CR7","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.neurobiolaging.2011.10.027","volume":"33","author":"G Dhawan","year":"2012","unstructured":"Dhawan G, Floden AM, Combs CK. Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging. 2012;33(10):2247\u201361.","journal-title":"Neurobiol Aging"},{"issue":"13","key":"1802_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.neuron.2023.04.007","volume":"111","author":"AM Stern","year":"2023","unstructured":"Stern AM, Yang Y, Jin S, Yamashita K, Meunier AL, Liu W, et al. Abundant Abeta fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron. 2023;111(13):2012-20 e4.","journal-title":"Neuron"},{"issue":"6","key":"1802_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62(6):788\u2013801.","journal-title":"Neuron"},{"issue":"6453","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, et al. A vicious cycle of beta amyloid-dependent neuronal hyperactivation. Science. 2019;365(6453):559\u201365.","journal-title":"Science"},{"issue":"18","key":"1802_CR11","doi-asserted-by":"publisher","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Y Gong","year":"2003","unstructured":"Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al. Alzheimer\u2019s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A. 2003;100(18):10417\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1802_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14(8):837\u201342.","journal-title":"Nat Med"},{"issue":"5","key":"1802_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem. 2007;101(5):1172\u201384.","journal-title":"J Neurochem"},{"issue":"1","key":"1802_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006304","volume":"2","author":"B De Strooper","year":"2012","unstructured":"De Strooper B, Iwatsubo T, Wolfe MS. Presenilins and gamma-secretase: structure, function, and role in Alzheimer Disease. Cold Spring Harb Perspect Med. 2012;2(1): a006304.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1802_CR15","doi-asserted-by":"crossref","unstructured":"Funke SA. Detection of Soluble Amyloid-beta Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease. Int J Alzheimers Dis. 2011;2011:151645.","DOI":"10.4061\/2011\/151645"},{"issue":"3","key":"1802_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349\u201357.","journal-title":"Nat Neurosci"},{"issue":"6","key":"1802_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/alz.12457","volume":"18","author":"L Liu","year":"2022","unstructured":"Liu L, Kwak H, Lawton TL, Jin SX, Meunier AL, Dang Y, et al. An ultra-sensitive immunoassay detects and quantifies soluble Abeta oligomers in human plasma. Alzheimers Dement. 2022;18(6):1186\u2013202.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1802_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/alzrt261","volume":"6","author":"H Feinberg","year":"2014","unstructured":"Feinberg H, Saldanha JW, Diep L, Goel A, Widom A, Veldman GM, et al. Crystal structure reveals conservation of amyloid-beta conformation recognized by 3D6 following humanization to bapineuzumab. Alzheimers Res Ther. 2014;6(3):31.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1802_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jneumeth.2008.09.002","volume":"176","author":"Z van Helmond","year":"2009","unstructured":"van Helmond Z, Heesom K, Love S. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. J Neurosci Methods. 2009;176(2):206\u201312.","journal-title":"J Neurosci Methods"},{"issue":"7","key":"1802_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/cn500105p","volume":"5","author":"P Nilsson","year":"2014","unstructured":"Nilsson P, Saito T, Saido TC. New mouse model of Alzheimer\u2019s. ACS Chem Neurosci. 2014;5(7):499\u2013502.","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"1802_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17(5):661\u20133.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1802_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W, Wang Z, Liu W, O\u2019Malley TT, Jin M, Willem M, et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain. Acta Neuropathol. 2018;136(1):19\u201340.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1802_CR23","doi-asserted-by":"publisher","first-page":"fcab147","DOI":"10.1093\/braincomms\/fcab147","volume":"3","author":"DI Sideris","year":"2021","unstructured":"Sideris DI, Danial JSH, Emin D, Ruggeri FS, Xia Z, Zhang YP, et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019s disease. Brain Commun. 2021;3(3):fcab147.","journal-title":"Brain Commun"},{"issue":"1","key":"1802_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Jin SX, Moors TE, Fonseca-Ornelas L, Shimanaka K, Lei S, et al. Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 2023;9(1):4.","journal-title":"NPJ Parkinsons Dis"},{"issue":"35","key":"1802_CR25","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1021\/bi001048s","volume":"39","author":"DM Walsh","year":"2000","unstructured":"Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 2000;39(35):10831\u20139.","journal-title":"Biochemistry"},{"issue":"7601","key":"1802_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature. 2016;533(7601):125\u20139.","journal-title":"Nature"},{"issue":"6","key":"1802_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1227\/01.NEU.0000313629.07947.66","volume":"63","author":"R Beyene","year":"2008","unstructured":"Beyene R, Boockvar JA. Disease-specific induced pluripotent stem cells. Neurosurgery. 2008;63(6):12.","journal-title":"Neurosurgery"},{"issue":"5","key":"1802_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785\u201398.","journal-title":"Neuron"},{"issue":"21","key":"1802_CR29","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.neuron.2021.08.003","volume":"109","author":"VN Lagomarsino","year":"2021","unstructured":"Lagomarsino VN, Pearse RV 2nd, Liu L, Hsieh YC, Fernandez MA, Vinton EA, et al. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron. 2021;109(21):3402-20 e9.","journal-title":"Neuron"},{"issue":"11","key":"1802_CR30","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1373\/clinchem.2007.091181","volume":"53","author":"J Todd","year":"2007","unstructured":"Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, et al. Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem. 2007;53(11):1990\u20135.","journal-title":"Clin Chem"},{"issue":"5","key":"1802_CR31","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","volume":"76","author":"RB Demattos","year":"2012","unstructured":"Demattos RB, Lu J, Tang Y, Racke MM, Delong CA, Tzaferis JA, et al. A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer\u2019s disease mice. Neuron. 2012;76(5):908\u201320.","journal-title":"Neuron"},{"issue":"24","key":"1802_CR32","doi-asserted-by":"publisher","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ. Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease. J Biol Chem. 1992;267(24):17082\u20136.","journal-title":"J Biol Chem"},{"key":"1802_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7554\/eLife.12727","volume":"5","author":"H Dana","year":"2016","unstructured":"Dana H, Mohar B, Sun Y, Narayan S, Gordus A, Hasseman JP, et al. Sensitive red protein calcium indicators for imaging neural activity. Elife. 2016;5:5.","journal-title":"Elife."},{"issue":"2","key":"1802_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.25513","volume":"86","author":"T Yang","year":"2019","unstructured":"Yang T, Dang Y, Ostaszewski B, Mengel D, Steffen V, Rabe C, et al. Target engagement in an alzheimer trial: Crenezumab lowers amyloid \u03b2 oligomers in cerebrospinal fluid. Ann Neurol. 2019;86(2):215\u201324.","journal-title":"Ann Neurol"},{"issue":"1","key":"1802_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","volume":"37","author":"T Yang","year":"2017","unstructured":"Yang T, Li S, Xu H, Walsh DM, Selkoe DJ. Large soluble oligomers of amyloid beta-protein from alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate. J Neurosci. 2017;37(1):152\u201363.","journal-title":"J Neurosci"},{"issue":"1","key":"1802_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.23748","volume":"73","author":"TJ Esparza","year":"2013","unstructured":"Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, et al. Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol. 2013;73(1):104\u201319.","journal-title":"Ann Neurol"},{"issue":"2","key":"1802_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0197-4580(01)00316-5","volume":"23","author":"BJ Cummings","year":"2002","unstructured":"Cummings BJ, Mason AJ, Kim RC, Sheu PC, Anderson AJ. Optimization of techniques for the maximal detection and quantification of Alzheimer\u2019s-related neuropathology with digital imaging. Neurobiol Aging. 2002;23(2):161\u201370.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1802_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N Engl J Med. 2000;343(7):450\u20136.","journal-title":"N Engl J Med"},{"issue":"17","key":"1802_CR39","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2009;106(17):7209\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1802_CR40","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.neuropsychologia.2007.11.035","volume":"46","author":"MA Trivedi","year":"2008","unstructured":"Trivedi MA, Schmitz TW, Ries ML, Hess TM, Fitzgerald ME, Atwood CS, et al. fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer\u2019s disease. Neuropsychologia. 2008;46(6):1667\u201378.","journal-title":"Neuropsychologia"},{"issue":"4","key":"1802_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jalz.2009.07.003","volume":"6","author":"NA Dennis","year":"2010","unstructured":"Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA, et al. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement. 2010;6(4):303\u201311.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1802_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/ana.22105","volume":"68","author":"YT Quiroz","year":"2010","unstructured":"Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillon G, et al. Hippocampal hyperactivation in presymptomatic familial Alzheimer\u2019s disease. Ann Neurol. 2010;68(6):865\u201375.","journal-title":"Ann Neurol"},{"issue":"1","key":"1802_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ana.20163","volume":"56","author":"BC Dickerson","year":"2004","unstructured":"Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004;56(1):27\u201335.","journal-title":"Ann Neurol"},{"issue":"3","key":"1802_CR44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65(3):404\u201311.","journal-title":"Neurology"},{"issue":"40","key":"1802_CR45","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.1523\/JNEUROSCI.2250-06.2006","volume":"26","author":"KA Celone","year":"2006","unstructured":"Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer\u2019s disease: an independent component analysis. J Neurosci. 2006;26(40):10222\u201331.","journal-title":"J Neurosci"},{"issue":"1","key":"1802_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","volume":"12","author":"RA Sperling","year":"2010","unstructured":"Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, et al. Functional alterations in memory networks in early Alzheimer\u2019s disease. Neuromolecular Med. 2010;12(1):27\u201343.","journal-title":"Neuromolecular Med"},{"issue":"9","key":"1802_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70(9):1158\u201366.","journal-title":"JAMA Neurol"},{"issue":"48","key":"1802_CR48","doi-asserted-by":"publisher","first-page":"17680","DOI":"10.1523\/JNEUROSCI.4740-11.2011","volume":"31","author":"D Putcha","year":"2011","unstructured":"Putcha D, Brickhouse M, O\u2019Keefe K, Sullivan C, Rentz D, Marshall G, et al. Hippocampal hyperactivation associated with cortical thinning in Alzheimer\u2019s disease signature regions in non-demented elderly adults. J Neurosci. 2011;31(48):17680\u20138.","journal-title":"J Neurosci"},{"issue":"9","key":"1802_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/jnen\/nlae053","volume":"83","author":"DH Oakley","year":"2024","unstructured":"Oakley DH, Chung M, Abrha S, Hyman BT, Frosch MP. beta-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains. J Neuropathol Exp Neurol. 2024;83(9):772\u201382.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1802_CR50","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5607\/en.2018.27.5.350","volume":"27","author":"L Li","year":"2018","unstructured":"Li L, Roh JH, Chang EH, Lee Y, Lee S, Kim M, et al. iPSC Modeling of Presenilin1 Mutation in Alzheimer\u2019s Disease with Cerebellar Ataxia. Exp Neurobiol. 2018;27(5):350\u201364.","journal-title":"Exp Neurobiol"},{"key":"1802_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2021.103631","volume":"114","author":"RJ Elsworthy","year":"2021","unstructured":"Elsworthy RJ, King MC, Grainger A, Fisher E, Crowe JA, Alqattan S, et al. Amyloid-beta precursor protein processing and oxidative stress are altered in human iPSC-derived neuron and astrocyte co-cultures carrying presenillin-1 gene mutations following spontaneous differentiation. Mol Cell Neurosci. 2021;114: 103631.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1802_CR52","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms24021226","volume":"24","author":"L Alvarez-Sanchez","year":"2023","unstructured":"Alvarez-Sanchez L, Pena-Bautista C, Ferre-Gonzalez L, Balaguer A, Baquero M, Casanova-Estruch B, et al. Assessment of plasma and cerebrospinal fluid biomarkers in different stages of alzheimer\u2019s disease and frontotemporal dementia. Int J Mol Sci. 2023;24(2):1226.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1802_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","volume":"15","author":"Y Guo","year":"2023","unstructured":"Guo Y, Shen XN, Wang HF, Chen SD, Zhang YR, Chen SF, et al. The dynamics of plasma biomarkers across the Alzheimer\u2019s continuum. Alzheimers Res Ther. 2023;15(1):31.","journal-title":"Alzheimers Res Ther"},{"key":"1802_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106356","volume":"189","author":"AL Wojdala","year":"2023","unstructured":"Wojdala AL, Bellomo G, Gaetani L, Toja A, Chipi E, Shan D, et al. Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP. Neurobiol Dis. 2023;189: 106356.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1802_CR55","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41598-024-51334-x","volume":"14","author":"P Kivisakk","year":"2024","unstructured":"Kivisakk P, Fatima HA, Cahoon DS, Otieno B, Chacko L, Minooei F, et al. Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer\u2019s disease. Sci Rep. 2024;14(1):629.","journal-title":"Sci Rep"},{"issue":"5","key":"1802_CR56","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/alz.12841","volume":"19","author":"NJ Ashton","year":"2023","unstructured":"Ashton NJ, Puig-Pijoan A, Mila-Aloma M, Fernandez-Lebrero A, Garcia-Escobar G, Gonzalez-Ortiz F, et al. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays. Alzheimers Dement. 2023;19(5):1913\u201324.","journal-title":"Alzheimers Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01802-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:08:37Z","timestamp":1757232517000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01802-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01802-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human research subjects received prior approval from the Mass General Brigham Institutional Review Board, and informed consent was obtained for all living human participants.\u00a0All mouse and rat procedures were approved by the Institutional Animal Care and Use Committee at BWH (IACUC protocol # 2016N000342 and 2016N000305).\u00a0iPSC lines were utilized following IRB review and approval through MGB\/BWH IRB (#2015P001676).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}